Beta Drugs (NSE:BETA) Valuation Rank


NSE:BETA Beta Drugs Ltd NSE:BETA
86 GF Score
Price ₹2,090.50
GF Value ₹1,968.77
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Beta Drugs Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Beta Drugs Valuation Rank Related Terms

NSE:BETA
86GF Score
Beta Drugs Ltd NSE:BETA
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beta Drugs (NSE:BETA) Overvalued in 2026?

Based on GuruFocus' analysis, Beta Drugs stock appears to be overvalued. The current stock price of ₹2,090.50 is trading 6.2% above its estimated GF Value™ of ₹1,968.77. GuruFocus considers Beta Drugs to be Fairly Valued.

Key valuation signals for NSE:BETA:

  • Valuation Rank:
  • GF Value™: ₹1,968.77 vs. price of ₹2,090.50 (6.2% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the NSE:BETA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beta Drugs Business Description

Address SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries, of which key revenue is derived from the sales made in India.
86GF Score

Get the complete analysis for NSE:BETA

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,090.50
Price
₹1,968.77
GF Value